TAT 2019 – International Congress on Targeted Anticancer Therapies: Information for Media Representatives

Media registration

ESMO welcomes media interested in obtaining information and reporting on cancer issues. Registration is free to bona fide journalists on presentation of a letter of assignment and a valid press card. Media representatives are required to observe and abide by the ESMO Media Policy which applies to all ESMO events.

Complete the Media Registration Form

Media registration in advance is strongly recommended although on-site registration will still be possible. Further information for press representatives will be made available over the following weeks.

Please contact the ESMO Press Office for any additional questions.

Third-party media activities

Media activities initiated by third parties during or in connection with TAT 2019, including, but not limited to:

• Meetings such as press conferences, media briefings, educational sessions for media representatives, as well as
• PR activities, such as press releases, news, articles, interviews, etc.

are subject to the ESMO Policy on Third-Party Media Activities.

This policy aims to guarantee proper and correct distribution of oncology and cancer-related information to media representatives in connection with the conference.

Press events in or outside the congress centre but concomitant with/or during breaks of the scientific programme of TAT 2019 are subject to ESMO Press Office approval.

Please submit your first request to the ESMO Press Office.

Blackout times

During Blackout times any media activity initiated by third parties is not allowed.

Publication schedule for accepted abstracts

Abstracts accepted for presentation at TAT 2019 as Proffered Paper (oral presentation) and Poster were published online on the ESMO website at 12:00 CET on Monday, 25 February 2019.

Contact

ESMO Press Office

E-mail: media@esmo.org